Intragastric distribution of ion-exchange resins: A drug delivery system for the topical treatment of the gastric mucosa

被引:43
作者
Burton, S
Washington, N
Steele, RJC
Musson, R
Feely, L
机构
[1] QUEENS MED CTR,DEPT SURG,NOTTINGHAM NG7 2UH,ENGLAND
[2] ABBOTT LABS,IDC,QUEENBOROUGH ME11 5EL,KENT,ENGLAND
关键词
D O I
10.1111/j.2042-7158.1995.tb03268.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Previous studies by this group on freeze-dried oral dosage forms containing finely-divided ion-exchange resins revealed prolonged gastric residence and uniform distribution within the stomach. The present study was carried out to ascertain whether this was due to freeze-drying, properties of the radiolabelled ionic exchange resin, or the small dosing volume used. Tc-99m-labelled cholestyramine resin was administered in two dosage forms, a freeze-dried tablet which dissolved in the oral cavity (orally dissolving tablet; ODT) and a 1.5 mL aqueous suspension. Two resin particle sizes (20-40 and 90-125 mu m) were studied. Oesophageal transit and intragastric distribution and residence were followed by gamma scintigraphy. In a second study, in six subjects, gastric emptying of the water-soluble fraction of the ODT and 1.5 mt of water, was measured using Tc-99m diethylenetriaminepentaacetic acid. Oesophageal transit of a water-soluble marker and resin in suspension was rapid, but the transit of the resin in the ODTs was significantly prolonged. Regardless of particle size or dosage form, the resin was evenly distributed throughout the stomach with 20-25% remaining for 5.5 h. In contrast, the water-soluble marker cleared from the stomach rapidly from both dosage forms. We suggest that oral dose forms containing finely-divided ion-exchange resins may form a useful system for topical treatment of the gastric mucosa, for example in targeting to Helicobacter pylori infection.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 12 条
[1]
DETECTION OF THE INTRAGASTRIC SITES AT WHICH HELICOBACTER-PYLORI EVADES TREATMENT WITH AMOXICILLIN AND CIMETIDINE [J].
ATHERTON, JC ;
COCKAYNE, A ;
BALSITIS, M ;
KIRK, GE ;
HAWKEY, CJ ;
SPILLER, RC .
GUT, 1995, 36 (05) :670-674
[2]
GLUPCZYNSKI Y, 1988, AM J GASTROENTEROL, V83, P365
[3]
MONITORING ANTACID PREPARATIONS IN THE STOMACH USING GAMMA SCINTIGRAPHY [J].
JENKINS, JRF ;
HARDY, JG ;
WILSON, CG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 14 (2-3) :143-148
[4]
AN ESTIMATE OF TURNOVER TIME OF INTESTINAL MUCUS GEL LAYER IN THE RAT INSITU LOOP [J].
LEHR, CM ;
POELMA, FGJ ;
JUNGINGER, HE ;
TUKKER, JJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 70 (03) :235-240
[5]
THE INFLUENCE OF THE INTERDIGESTIVE MIGRATING MYOELECTRIC COMPLEX ON THE GASTRIC-EMPTYING OF LIQUIDS [J].
OBERLE, RL ;
CHEN, TS ;
LLOYD, C ;
BARNETT, JL ;
OWYANG, C ;
MEYER, J ;
AMIDON, GL .
GASTROENTEROLOGY, 1990, 99 (05) :1275-1282
[6]
CAMPYLOBACTER-PYLORIDIS-ASSOCIATED CHRONIC ACTIVE ANTRAL GASTRITIS - A PROSPECTIVE-STUDY OF ITS PREVALENCE AND THE EFFECTS OF ANTIBACTERIAL AND ANTIULCER TREATMENT [J].
RAUWS, EA ;
LANGENBERG, W ;
HOUTHOFF, HJ ;
ZANEN, HC ;
TYTGAT, GNJ .
GASTROENTEROLOGY, 1988, 94 (01) :33-40
[7]
A GAMMA-SCINTIGRAPHIC STUDY OF GASTRIC COATING BY EXPIDET, TABLET AND LIQUID FORMULATIONS [J].
WASHINGTON, N ;
WILSON, CG ;
GREAVES, JL ;
NORMAN, S ;
PEACH, JM ;
PUGH, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 57 (01) :17-22
[8]
EFFECT OF TIME OF DOSING RELATIVE TO A MEAL ON THE RAFT FORMATION OF AN ANTI-REFLUX AGENT [J].
WASHINGTON, N ;
GREAVES, JL ;
WILSON, CG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (01) :50-53
[9]
A GAMMA SCINTIGRAPHIC STUDY TO COMPARE ESOPHAGEAL CLEARANCE OF EXPIDET FORMULATIONS, TABLETS AND CAPSULES IN SUPINE VOLUNTEERS [J].
WILSON, CG ;
WASHINGTON, N ;
NORMAN, S ;
GREAVES, JL ;
PEACH, JM ;
PUGH, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 46 (03) :241-246
[10]
BIMODAL RELEASE OF IBUPROFEN IN A SUSTAINED-RELEASE FORMULATION - A SCINTIGRAPHIC AND PHARMACOKINETIC OPEN STUDY IN HEALTHY-VOLUNTEERS UNDER DIFFERENT CONDITIONS OF FOOD-INTAKE [J].
WILSON, CG ;
WASHINGTON, N ;
GREAVES, JL ;
KAMALI, F ;
REES, JA ;
SEMPIK, AK ;
LAMPARD, JF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 50 (02) :155-161